New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...
U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis ...
When Wizards of the Coast launched the Pokémon trading card game in North America in January 1999 — just months after Pokémon ...
The Mary Sue on MSN
Woman forgets how pad size works after a hysterectomy and ends up bringing post-birth-size pads for her sister
We often joke that once you leave a certain phase of life, your brain deletes the operational data associated with it. For TikTok creator Selina Rae (@therealrealwitraerae), that data loss involved ...
OKLAHOMA CITY, OK / ACCESS Newswire / February 26, 2026 / Feed the Children is teaming up with the culinary competition series Next Level Chef and FOX to fight childhood hunger through Put Child Hunge ...
PSA's February 2026 Price Hike Details PSA implemented these psa grading price increases in February 2026 to match surging demand with operational capacity, ensuring more reliable service delivery.
Public Storage is one of the world's largest self-storage REITs, with a $52.85B market cap and robust asset base. Learn more about PSA stock here.
A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results